MomTreatment Dashboard

Lana Markey · Study 2023-0621 · Dr. Andreeff, MD Anderson
Latest labs: 2026-05-13 · Built 2026-05-13 09:41:26
This dashboard refreshes automatically every day at 9:30 AM CT
build#83286 · motion=on
TODAY · WEDNESDAY
May 13, 2026
Cycle 1
Day 24 of 35 · Watch week
69% through Cycle 1 · 19% through the first 4 cycles (trial can run up to 2 years)
Medicine schedule
💉NadunolimabNext in 12 days (May 25)
💉AzacitidineWeek starts in 12 days (May 25)

What Mom's Labs Say Today

Auto-generated from Mom's MyChart labs with AI assistance. This is an informational summary, not medical advice or a clinical assessment — any questions or concerns should go to her care team at MD Anderson. Every number cites a date; causal claims are hedged.

Mom is on Cycle 1 Day 24 of 35 (2026-05-13). Her peripheral blast count was 1.0% on 2026-04-29, down from a peak of 5.0% on 2026-04-23. The first Nadunolimab infusion was given Apr 20. The timing of the decline is consistent with that drug contributing, but blast counts were already trending down before the infusion, so we can't confidently attribute the drop to any single factor. Azacitidine doesn't start until Day 8 of the cycle.

Hemoglobin is 8.2 g/dL on 2026-05-13. Platelets are 23.0 K/uL — at/near the 20 transfusion threshold. ANC (neutrophils) is 0.09 K/uL on 2026-05-13 — this is severe neutropenia. Any fever above 100.4°F requires an immediate call to MDA. Day 3 of induction is early for chemo-driven nadir (typically Day 10-14). Today's low ANC (neutrophils) most likely reflects her underlying MDS marrow failure more than a direct effect of Nadunolimab.

ALT is 16.0 U/L on 2026-05-13 — within the reference range. Kidney function looks stable (creatinine 0.82 mg/dL on 2026-05-13).

Transfusions in the last 7 days: 2026-05-11 PRBC (red cells) (inferred). Note: MDA typically draws morning labs just after midnight, so a transfusion given overnight will not show up until the next day's draw.

How Mom's Likely Feeling Today 💛

🌬️ Energy & breath. Hemoglobin 8.2 g/dL on 2026-05-13 is mildly low — she's probably tired, and likely a bit easily winded climbing stairs or talking for long stretches.

💧 Hydration. Creatinine, BUN, and sodium are all trending up over the last few days while potassium has dipped — a textbook signature of fluid running a little behind. She's likely thirsty, possibly with a dry mouth, and may feel lightheaded standing up.

🛡️ Infection vulnerability. ANC (neutrophils) 0.09 on 2026-05-13 is severe neutropenia. She likely feels normal on this front — neutropenia itself is silent — but she's vulnerable. The team is on this; any fever ≥ 100.4°F triggers immediate workup.

Net read: today's numbers describe a body being asked to do a hard thing and holding up. Tired, watched closely, no surprises.

What changed today
Biggest day-over-day shifts — 2026-05-12 → 2026-05-13
White Blood Cells: 0.9 → 3.1 (+2.2 K/uL)
Improved out of the alert zone into watch. Good direction.
ANC (neutrophils): 0.2 → 0.1 (−0.1 K/uL)
Neutrophils trending down — expected during induction.
BUN: 19 → 25 (+6 mg/dL)
Crossed into a watch zone — was normal. Worth flagging.
1The Journey
Treatment timeline and what's coming up
This is the tentative plan right now. Nothing is locked in. The team will adjust based on how Mom responds, how her body handles each drug, and whether transplant becomes a real option. She could do fewer cycles, or more. Dates can shift. Treatment can continue up to 2 years total. Think of this as the current roadmap, not a fixed schedule.
The journey · First 4 cycles shown · Apr 20 → Aug 16 (may continue)
← swipe to see the full timeline →
C1
C2
C3
C4
Apr 20
May 24
Jun 21
Jul 19
Aug 16
Today
Nadunolimab infusion
Azacitidine week
Watch week (nadir)
Note: The trial can run up to 2 years. This chart shows the first 4 cycles as the initial window — Mom may continue past Aug 16 depending on her response and when a transplant is ready.
What's coming up
In 11 days
End of Cycle 1 · bone marrow biopsy
Sunday · May 24
In 12 days
Nadunolimab infusion
Monday · May 25
In 12 days
Azacitidine week begins
Monday · May 25
2The Numbers
Daily labs, transfusions, and the full data

Transfusions

7 detected — confirmed entries come from the manual log; inferred entries are deduced from lab jumps.
🩸 Transfusion log (7)
2026-04-02PRBC (1 unit)Pre-MDA transfusion at Aspirus. Hgb 8.0 → post-transfusion dilutional labs at MDA admit.(confirmed)
2026-04-06PRBC (red cells)Hgb +2.9, RDW -0.8 (revealed 2026-04-07 AM draw)(inferred from labs)
2026-04-11PRBC (red cells)Hgb +1.0, RDW +1.9 (revealed 2026-04-12 AM draw)(inferred from labs)
2026-04-22PRBC (red cells)Hgb +1.2, RDW +0.4 (revealed 2026-04-23 AM draw)(inferred from labs)
2026-04-24PRBC (red cells)Hgb +1.4, RDW -1.6 (revealed 2026-04-25 AM draw)(inferred from labs)
2026-05-01PRBC (red cells)Hgb +1.4, RDW -0.8 (revealed 2026-05-02 AM draw)(inferred from labs)
2026-05-11PRBC (red cells)Hgb +1.2, RDW -0.3 (revealed 2026-05-12 AM draw)(inferred from labs)

Blood Work

Daily labs from MD Anderson, ordered by day-to-day importance.
Green · on trackYellow · watchingRed · needs attention
Ordered by importance. The top row is what matters most day-to-day: ANC (infection risk), Hemoglobin (oxygen/energy), Platelets (bleeding risk), Blast % (disease activity), and RDW (marrow health).
= transfusion day (same as the 🩸 in the Full Data table)
Blood Counts — the daily headline numbers
1
ANC (neutrophils)
0.09K/uL▼ -0.11
Target ≥1.95 · ≤7.25 (MDA ref) · ↑ higher is better
The specific cells that fight bacteria. Under 1.0 + any fever = call the nurse right away.
2
Hemoglobin
8.2g/dL▼ -0.9
Target ≥12.2 · ≤15.3 (MDA ref) · ↑ higher is better
Carries oxygen through the body. Low = tired, short of breath. Transfusion likely under 8.
3
Platelets
23K/uL▼ -2
Target ≥160.0 · ≤397.0 (MDA ref) · ↑ higher is better
Tiny cells that stop bleeding. Low = bruising, bleeding. Transfusion likely under 20.
4
Peripheral blasts
1%
Target ≤0.0 (MDA ref) · ↓ lower is better
Immature cancer cells in the bloodstream. Goal is 0%. Lower = better.
5
RDW
17.2%
Target ≥11.6 · ≤15.5 (MDA ref) · ↓ lower is better
How uneven the red blood cells are in size. Rising means her marrow is working harder.
6
White Blood Cells
3.1K/uL▲ +2.2
Target ≥4.1 · ≤10.5 (MDA ref) · ↑ higher is better
Total immune cells. Low = more vulnerable. Very high could mean infection or disease activity.
Chemistry — liver, kidneys, nutrition
7
ALT
16U/L▼ -1
Target ≤33.0 (MDA ref) · ↓ lower is better
Liver enzyme. Leaks out when liver cells are a little irritated. One she's watching.
8
AST
14U/L▼ -1
Target ≤32.0 (MDA ref) · ↓ lower is better
Another liver enzyme, pairs with ALT. Rising together means the liver wants a rest.
9
LDH
169U/L▼ -6
Target ≥135.0 · ≤214.0 (MDA ref) · ↓ lower is better
Leaks out when cells die fast. Falling means treatment is working. Rising = more turnover.
10
Creatinine
0.82mg/dL▲ +0.08
Target ≥0.51 · ≤0.95 (MDA ref) · ↓ lower is better
Best kidney function marker. Stable = kidneys happy. Chemo doses depend on this.
11
BUN
25mg/dL▲ +6
Target ≥6.0 · ≤23.0 (MDA ref) · ↓ lower is better
Kidney waste product. Rising can mean she needs more fluids or the kidneys are working hard.
12
Bilirubin
0.3mg/dL
Target ≥0.0 · ≤1.2 (MDA ref) · ↓ lower is better
Liver waste product. High can cause yellowing — hers is totally fine.
13
Alk Phos
94U/L▼ -16
Target ≥35.0 · ≤104.0 (MDA ref) · ↓ lower is better
Another liver/bile marker. Stable = plumbing's working.
14
Albumin
3.2g/dL▼ -0.4
Target ≥3.5 · ≤5.2 (MDA ref) · ↑ higher is better
Main blood protein. Low = could use more nutrition. Hers is a bit low.
Electrolytes — the balance panel
15
Potassium
4.4mmol/L
Target ≥3.4 · ≤4.5 (MDA ref) · stay in range
Electrolyte. Right balance keeps the heart happy. Team watches this closely.
16
Uric acid
3.6mg/dL▲ +0.5
Target ≥2.4 · ≤5.7 (MDA ref) · stay in range
Waste from cells that are dying off. Allopurinol keeps it controlled.
17
Calcium
8.5mg/dL▼ -0.1
Target ≥8.2 · ≤10.2 (MDA ref) · stay in range
Electrolyte for bones, muscles, heart.
18
Phosphorus
4.2mg/dL▲ +1.4
Target ≥2.5 · ≤4.5 (MDA ref) · stay in range
Electrolyte the team watches when cancer cells are dying off.
19
Magnesium
2mg/dL▲ +0.1
Target ≥1.6 · ≤2.6 (MDA ref) · stay in range
Electrolyte for muscles, nerves, heart. Easy to top up if low.

Full Data

Every value, every day. Colored cells flag out-of-range. 🩸 marks transfusion days.
Full Data
← swipe to see all dates →
Metric04-0104-0704-0804-0904-1004-11 🩸04-1204-1304-1404-1504-1604-1704-1804-1904-2004-2104-22 🩸04-2304-24 🩸04-2504-2604-2704-2804-2904-3005-01 🩸05-0205-0305-0405-0505-0605-0705-0805-0905-1005-11 🩸05-1205-13
ANC (neutrophils)4.463.872.193.574.264.353.531.932.342.191.311.071.021.30.82.940.482.061.531.141.21.090.810.680.210.380.230.130.140.190.190.280.220.060.020.080.20.09
Hemoglobin810.99.498.37.78.78.88.98.48.58.68.38.58.18.37.897.89.29.28.7998.47.89.29.49.39.59.29.68.98.58.37.99.18.2
Platelets6356525049515557575764666260584952474139404143444438363735363132282524242523
Peripheral blasts4451266411121013141075235332311
RDW21.220.420.320.520.119.721.620.820.520.220.120.120.220.420.520.820.721.120.518.918.918.418.518.618.818.918.118.11817.917.717.817.617.717.817.517.217.2
White Blood Cells6.757.97.38.38.26.97.59.298.17.77.16.85.45.74.24.47.15.95.74.34.22.63.432.42.53.33.53.13.23.53.132.32.50.93.1
ALT1227272524415961575044403438414945352420171718181516232322201716151717161716
AST121717181631383428222322202223302416912131311131011161614111212131516141514
LDH196206193174152157178179154159178178158177181230216167148160164130150135134125126133140141144155146148158153175169
Creatinine0.810.960.90.910.80.820.720.790.720.720.780.890.830.881.060.950.840.720.640.720.680.610.710.860.770.740.940.870.890.860.820.760.750.910.740.770.740.82
BUN24262020262928273031293227323129241919171824251819232123222221232320221925
Bilirubin0.60.40.70.40.30.30.30.30.30.30.30.30.30.30.30.30.60.40.30.40.30.30.40.50.30.40.60.40.30.50.60.30.30.30.30.30.3
Alk Phos887675746967667367677271767680737065716762666158545755576062717474869011094
Albumin3.63.332.92.82.72.82.82.82.82.93.13.23.23.23.23.22.92.92.92.932.932.92.93.13.23.33.43.63.53.33.43.33.63.2
Potassium4.64.74.14.54.44.44.54.44.444.23.944.24.73.743.93.74.34.14.13.53.83.943.84.344.44.44.44.54.34.74.44.4
Uric acid32.62.32.122.12.22.12.22.52.62.72.43.13.23.12.72.62.82.62.62.92.92.72.92.82.93.13.33.33.33.63.43.23.13.6
Calcium99.38.899.18.98.98.88.99.198.898.898.88.78.88.88.9998.68.89.39.199.19.29.19.18.98.88.68.5
Phosphorus4.13.73233.133.53.53.73.83.53.72.82.53.73.43.13.73.33.23.63.43.13.53.63.33.13.43.844.13.63.82.84.2
Magnesium2.32.12.22.22.12.32.22.42.22.12.1221.821.81.81.91.91.91.81.91.81.82.12.22.22.32.22.221.91.91.91.92
3The Plan
Each drug, the cycle structure, and watch weeks

The Regimen

What each drug does, why it's in her protocol, and when she takes it.
Study 2023-0621 · MD Anderson · Dr. Michael Andreeff
What she has: High-risk MDS (myelodysplastic syndrome) with TP53 mutation and 17p deletion. A bone-marrow condition that traces back to chemo she had for breast cancer in 1993. She's formally MDS (7% immature cells), treated carefully because of her TP53 gene.
The plan: Two medicines teaming up, cycle by cycle (1 cycle ≈ 1 month). Trial can run up to 2 years. Goal: quiet the disease down enough to move toward a stem cell transplant — which offers the chance to heal fully. Transplant timing depends on her response, not a fixed number of cycles.
Nadunolimabinvestigational antibody, IV
🎯 Smart missile
Targets the cells that drive the disease, while leaving healthy cells alone.
C1: Days 1, 8, 22. C2+: Days 1 and 15 (every 2 weeks).
Azacitidine (AZA)FDA-approved, IV or small injection
🔄 Reset button
Flips helpful genes back on so cells behave more normally.
C1: Days 8–14 (7 days). C2+: Days 1–7 of each cycle.
C1Apr 20–May 24C2May 25–Jun 21C3Jun 22–Jul 19C4Jul 20–Aug 16
She's Now In Cycle 1
The First Four Cycles
Cycle 1Apr 20 – May 24
Starting strong. Both medicines begin (Nadunolimab + Azacitidine).
Cycle 2May 25 – Jun 21
If counts recover and the team clears it, possible move to Rotary House. Nothing about this is locked in — depends entirely on her response and the team's call.
Cycle 3Jun 22 – Jul 19
Possible chance to come home for a stretch if she's ready. Tentative — depends on response.
Cycle 4Jul 20 – Aug 16
Team evaluates response — could lead to transplant or more cycles.
Beyond Cycle 4Aug 16 +
Trial can run up to 2 years. Treatment continues cycle by cycle as long as she's responding. Stem cell transplant happens whenever the team says she's ready and a donor match is confirmed — could be sooner, could be later.

Watch Weeks

Rough estimates of when Mom's blood counts might be at their lowest each cycle. These are educated guesses based on typical Azacitidine-induction timing. Her actual lowest week can shift earlier or later, can last longer, and might not always be the first cycle. The team watches her daily regardless, so think of these more as heads-up windows than hard predictions.
Magnifying glass over blood cells
May 04 – May 18Cycle 1 watch window — Rough estimate of when her blood counts could be at their lowest during this cycle. Actual timing varies a lot patient to patient.
Jun 08 – Jun 21Cycle 2 watch window — Another likely dip window. Nadirs can get deeper over time, or not. Team adjusts as they learn her pattern.
Jul 05 – Jul 19Cycle 3 watch window — Third estimated dip. By now the team has a better feel for her rhythm, and these windows may shift.
Aug 03 – Aug 16Cycle 4 watch window — Last dip before a possible transplant conversation, depending on how she's responding.
We ❤️ You Mom!